Trial intelligence / Profile preview

Anakinra for Fever and Mucositis in Multiple Myeloma ASCT

NCT04099901Phase 2Completed

Sponsor
Radboud University Medical Center
Start
Nov 2019
Primary completion
Mar 2023
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of anakinra in febrile neutropenia (FN), mucositis, sponsored by Radboud University Medical Center. Started Nov 2019; status: completed.

02

Drugs

anakinra
03

Conditions

febrile neutropenia (FN)mucositis

Beyond the preview

Go deeper on NCT04099901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04099901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call